(Q38397568)

2 September 2017

title

Prognostic significance of BRCA1-associated protein 1 in colorectal cancer (English)

1 reference

2 September 2017

1 reference

Jianjun Tang

1

1 reference

2 September 2017

Shaoyan Xi

2

1 reference

2 September 2017

Gang Wang

3

1 reference

2 September 2017

Boqing Wang

4

1 reference

2 September 2017

Shumei Yan

5

1 reference

2 September 2017

Yuanzhong Wu

6

1 reference

2 September 2017

Yi Sang

7

1 reference

2 September 2017

Wenjing Wu

8

1 reference

2 September 2017

Ruhua Zhang

9

1 reference

2 September 2017

Tiebang Kang

10

1 reference

2 September 2017

publication date

23 March 2013

1 reference

2 September 2017

1 reference

2 September 2017

volume

30

1 reference

2 September 2017

issue

2

1 reference

2 September 2017

page(s)

541

1 reference

https://scigraph.springernature.com/pub.10.1007/s12032-013-0541-8

2 September 2017

exact match

0 references

cites work

Current management of colorectal hepatic metastasis

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0541-8

Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0541-8

Epigenetic changes in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0541-8

BRCA1-associated protein-1 is a tumor suppressor that requires deubiquitinating activity and nuclear localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0541-8

ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0541-8

Histone H2A deubiquitinase activity of the Polycomb repressive complex PR-DUB

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0541-8

Profiling of UV-induced ATM/ATR signaling pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0541-8

Frequent mutation of BAP1 in metastasizing uveal melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0541-8

The deubiquitinating enzyme BAP1 regulates cell growth via interaction with HCF-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0541-8

An emerging model for BAP1's role in regulating cell cycle progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0541-8

Expression of DNA double-strand break repair proteins ATM and BRCA1 predicts survival in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0541-8

Loss of the tumor suppressor BAP1 causes myeloid transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0541-8

BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0541-8

Defining biochemical functions for the BRCA1 tumor suppressor protein: analysis of the BRCA1 binding protein BAP1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0541-8

BRCA1-associated protein 1 interferes with BRCA1/BARD1 RING heterodimer activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0541-8

BAP1 loss defines a new class of renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0541-8

Glycogen synthase kinase-3β, NF-κB signaling, and tumorigenesis of human osteosarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0541-8

hSSB1 binds and protects p21 from ubiquitin-mediated degradation and positively correlates with p21 in human hepatocellular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0541-8

GSK-3 beta targets Cdc25A for ubiquitin-mediated proteolysis, and GSK-3 beta inactivation correlates with Cdc25A overproduction in human cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0541-8

CHK1 targets spleen tyrosine kinase (L) for proteolysis in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0541-8

The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0541-8

Germline BAP1 mutations predispose to malignant mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0541-8

Germline mutations in BAP1 predispose to melanocytic tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0541-8

Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0541-8

Clinically important aspects of lymph node assessment in colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0541-8

Mechanisms of lymphatic metastasis in human colorectal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0541-8

hSSB1 regulates both the stability and the transcriptional activity of p53

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23526420

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

BAP1 is a good prognostic factor in advanced non-small cell lung cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23526420

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S12032-013-0541-8

1 reference

Dimensions Publication ID

2 September 2017

1053449905

0 references

1 reference